Press Releases
Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand
Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health...
TriNetX Announces the Appointment of Arnaub Chatterjee as Chief Product and Solutions Officer
Cambridge, MA, February 14, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Arnaub Chatterjee has joined the company as Chief Product and Solutions Officer....
TriNetX Announces the Appointment of Shields Carstarphen as Chief Commercial Officer
Cambridge, MA, January 17, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Shields Carstarphen has joined the company as Chief Commercial Officer. “We are...
South Tees Hospitals NHS Foundation Trust Joins TriNetX to Increase Research Opportunities
Cambridge, MA, December 15, 2022 — South Tees Hospitals NHS Foundation Trust, one of the most active research organizations in the northeast of England, has joined the TriNetX network to increase its visibility to commercial partners for additional research...
TriNetX Launches LUCID Trusted Research Environment for Real-World Evidence Generation
Researchers can now run complex data analytics and artificial intelligence/machine learning using TriNetX to unlock new opportunities with remarkable clinical detail Cambridge, MA, October 20, 2022 — TriNetX, the global network of healthcare organizations driving...
TriNetX Acquires European Regulatory-Grade Real-World Evidence Leader OncologyInformationService and CancerDataNet
Cambridge, MA, October 18, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the acquisition of OncologyInformationService e.K. (OIS) and its subsidiary...